David Lalloo
David Lalloo is a prominent clinical researcher at the Liverpool School of Tropical Medicine, known for his expertise in tropical medicine and snakebite treatment. His work has highlighted significant issues in the regulation and testing of antivenoms, particularly in sub-Saharan Africa. Lalloo has emphasized the necessity for rigorous clinical studies to ensure the safety and efficacy of antivenoms, advocating for better standards in the treatment of snakebite victims globally.
Global Media Ratings
Countries Mentioned
| Country | Mentions | Sentiment | Dominance | + Persistence | x Population | = Reach | x GDP (millions) | = Power |
|---|---|---|---|---|---|---|---|---|
| South Africa | 1 | 6.00 | 0.40% | +0% | 59,308,690 | 240,116 | $350,000 | 1,417$ |
| Totals | 1 | 59,308,690 | 240,116 | $350,000 | 1,417$ |
Interactive World Map
Each country's color is based on "Mentions" from the table above.
Recent Mentions
South Africa:
David Lalloo, a clinical researcher at the Liverpool School of Tropical Medicine, said the regulation of antivenoms 'has just not been as tight as it should be' for patients around the world.
6